Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Recurrence: early-phase trial registry
4 of 9 indexed Recurrence trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Recurrence: 9 US clinical trials tracked, 4 recruiting.
Recurrence is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Arsenal Biosciences, running 2 of these trials.
Enrollment posture brief
Registry condition recurrence
OPEN 4 | RECR 44% | LATE 1 | EARLY 2 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Recurrence lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Recurrence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Recurrence is recruiting below its size-band peers.
4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Recurrence research.
Arsenal Biosciences accounts for 2 of 9 trials (22.2%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Recurrence enrolment sits around 210 participants.
Median target enrolment is 210 among the 9 trials that report a genuine target (sentinel values excluded). 2 of those (22.2%) plan for fewer than 100 participants.
-
Recurrence splits between interventional and observational designs.
5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
White River Junction Veterans Affairs Medical Center
NCT04220905
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Memorial Sloan Kettering Cancer Center
NCT07030686
xDRIVE for Florida-based Cancer Patients
First Ascent Biomedical
NCT07167381
Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System
The Cleveland Clinic
NCT06379321
Cold Snare Endoscopic Mucosal Resection Trial
White River Junction Veterans Affairs Medical Center
NCT03865537
Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression
University of Illinois at Chicago
NCT05331599
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Arsenal Biosciences
NCT06245915
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
Arsenal Biosciences
NCT05617755
Relapse Prevention With Varenicline
Johns Hopkins University
NCT00944554
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Recurrence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Recurrence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Recurrence page
9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Recurrence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Arsenal Biosciences sponsors the most Recurrence trials on record, review their full trial history before evaluating a specific study. See Arsenal Biosciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recurrence condition card totals 9 registered trials; most-linked intervention AB-1015; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.